Multiplex bioimaging of piRNA molecular pathway-regulated theragnostic effects in a single breast cancer cell using a piRNA molecular beacon

Abstract Recently, PIWI-interacting small non-coding RNAs (piRNAs) have emerged as novel cancer biomarkers candidate because of their high expression level in various cancer types and role in the control of tumor suppressor genes. In this study, a novel breast cancer theragnostics probe based on a s...

Full description

Saved in:
Bibliographic Details
Published inBiomaterials Vol. 101; pp. 143 - 155
Main Authors Lee, Youn Jung, Moon, Sung Ung, Park, Min Geun, Jung, Woon Yong, Park, Yong Keun, Song, Sung Kyu, Ryu, Je Gyu, Lee, Yong Seung, Heo, Hye Jung, Gu, Ha Na, Cho, Su Jeong, Ali, Bahy A, Al-Khedhairy, Abdulaziz A, Lee, Ilkyun, Kim, Soonhag
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 01.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Recently, PIWI-interacting small non-coding RNAs (piRNAs) have emerged as novel cancer biomarkers candidate because of their high expression level in various cancer types and role in the control of tumor suppressor genes. In this study, a novel breast cancer theragnostics probe based on a single system targeting the piRNA-36026 (piR-36026) molecular pathway was developed using a piR-36026 molecular beacon (MB). The piR-36026 MB successfully visualized endogenous piR-36026 biogenesis, which is highly expressed in MCF7 cells (a human breast cancer cell line), and simultaneously inhibited piR-36026-mediated cancer progression in vitro and in vivo . We discovered two tumor suppressor proteins, SERPINA1 and LRAT, that were directly regulated as endogenous piR-36026 target genes in MCF7 cells. Furthermore, multiplex bioimaging of a single MCF7 cell following treatment with piR-36026 MB clearly visualized the direct molecular interaction of piRNA-36026 with SERPINA1 or LRAT and subsequent molecular therapeutic responses including caspase-3 and PI in the nucleus.
ISSN:0142-9612
1878-5905
DOI:10.1016/j.biomaterials.2016.05.052